A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin

Name: A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin
Published: 2023
License: Public Domain

Pfizer · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

coronavirus-disease-2019-covid-19 pharmacokinetics

pharmacokinetics, healthy volunteers, coronavirus disease 2019 (covid-19), severe acute respiratory syndrome coronavirus 2 (sars-cov-2), nirmatrelvir, paxlovid, rosuvastatin, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin

Related documents